Mlg22-ve14.cme-lms.com is a subdomain of cme-lms.com, which was created on 2020-02-21,making it 4 years ago. It has several subdomains, such as mlg23-7.cme-lms.com , among others.
Description:Saturday, June 4, 2022 7:45 PM – 8:45 PM ET 6:45 PM – 7:45 PM CT 5:45 PM – 6:45 PM MT 4:45 PM – 5:45 PM PT Learning Objectives After participating in this educational initiative, clinicians should...
Discover mlg22-ve14.cme-lms.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 30.094 KB |
Page Load Time: 0.378973 Seconds |
Website IP Address: 54.81.210.91 |
Patients & Families | Patients & Families | UW Health patient.uwhealth.org |
PatientsLikeMe Blog | Patients Helping Patients Live Better Every Day blog.patientslikeme.com |
Women Role Models in STEAM | Video interviews of successful women in Science, Technology, Engineerin steam.pamvanlonden.com |
Associated | Disability and Inclusion Resources | Associated baltimore.jewishabilities.org |
The Role and Value of Nuclear Medicine in the Imaging of manage.nuclearnode.com |
Associated Students | Associated Students asi.sfsu.edu |
Fellows Hall - General High Fantasy Role-Playing and discussions of G.R.R. Martin's World. fellowshall.yuku.com |
play a critical role in our success | Oceana Gold careers.oceanagold.com |
Medical office software that unifies every role of the practice | AdvancedMD learnmore.advancedmd.com |
Find your role | Terminix jobs.terminix.com |
MD Anderson Cancer Center: Cancer Treatment & Cancer Research Hospital | MD Anderson Cancer Center www3.mdanderson.org |
Cancer Epigenetics | A journal of the Cancer Epigenetics Society | Cancer Epigenetics ce.b2sg.org |
Vein academy - A new website for venous disease by vein-academy.servier.com |
Role-Playing Game Research — RPG Research, we use music & role-playing games to help people heal & w3.rpgresearch.com |
Optimal Management of Patients with Cancer-associated ... http://mlg22-ve14.cme-lms.com/ |
Sign In http://mlg22-ve14.cme-lms.com/signin/ |
Date: Wed, 15 May 2024 01:51:21 GMT |
Server: Apache |
X-Powered-By: PHP/7.3.11 |
X-Pingback: http://mlg22-ve14.cme-lms.com/xmlrpc.php |
Link: http://mlg22-ve14.cme-lms.com/wp-json/; rel="https://api.w.org/", http://mlg22-ve14.cme-lms.com/; rel=shortlink |
X-Mod-Pagespeed: 1.13.35.2-0 |
Vary: Accept-Encoding |
Cache-Control: max-age=0, no-cache, s-maxage=10 |
Content-Length: 28054 |
Content-Type: text/html; charset=UTF-8 |
charset="utf-8"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy" name="title"/ |
content="" name="description"/ |
content="Saturday, June 4, 2022 7:45 PM – 8:45 PM ET 6:45 PM – 7:45 PM CT 5:45 PM – 6:45 PM MT 4:45 PM – 5:45 PM PT Learning Objectives After participating in this educational initiative, clinicians should be better able to: Facilitate optimal management of patients with cancer-associated VTE based on risk stratification assessments" name="description" |
content="max-image-preview:large" name="robots" |
content="All in One SEO (AIOSEO) 4.5.3.1" name="generator"/ |
content="en_US" property="og:locale"/ |
content="Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy -" property="og:site_name"/ |
content="website" property="og:type"/ |
content="Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy - Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy" property="og:title"/ |
content="Saturday, June 4, 2022 7:45 PM – 8:45 PM ET 6:45 PM – 7:45 PM CT 5:45 PM – 6:45 PM MT 4:45 PM – 5:45 PM PT Learning Objectives After participating in this educational initiative, clinicians should be better able to: Facilitate optimal management of patients with cancer-associated VTE based on risk stratification assessments" property="og:description"/ |
content="http://mlg22-ve14.cme-lms.com/" property="og:url"/ |
content="summary_large_image" name="twitter:card"/ |
content="Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy - Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy" name="twitter:title"/ |
content="Saturday, June 4, 2022 7:45 PM – 8:45 PM ET 6:45 PM – 7:45 PM CT 5:45 PM – 6:45 PM MT 4:45 PM – 5:45 PM PT Learning Objectives After participating in this educational initiative, clinicians should be better able to: Facilitate optimal management of patients with cancer-associated VTE based on risk stratification assessments" name="twitter:description"/ |
content="WordPress 5.4.15" name="generator"/ |
Ip Country: United States |
City Name: Ashburn |
Latitude: 39.0469 |
Longitude: -77.4903 |
Anticoagulation Therapy - Anticoagulation Therapy Sign In Register Home CME Program Anticoagulation Therapy Anticoagulation Therapy Saturday, June 4, 2022 7:45 PM – 8:45 PM ET 6:45 PM – 7:45 PM CT 5:45 PM – 6:45 PM MT 4:45 PM – 5:45 PM PT Learning Objectives After participating in this educational initiative, clinicians should be better able to: Facilitate optimal management of patients with cancer-associated VTE based on risk stratification assessments Assess data from clinical trials supporting anticoagulants for the treatment of patients with cancer-associated VTE Select appropriate therapies for patients with cancer-associated VTE using recently updated evidence-based guidance from professional organizations Optimize outcomes for patients with cancer-associated VTE through adoption of multidisciplinary patient-centered SDM management approaches Target Audience This activity is intended for medical oncologists, community oncologists, primary care providers, allied healthcare professionals ie, nurse practitioners, physician assistants, pharmacists, VTE specialists, and/or other healthcare professionals involved in the care of patients with cancer. Accreditation Statement Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials. Credit Designation Statement Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) TM . Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity. Nursing Credit Information Purpose: Education regarding the management of VTE in cancer leads to safe practices, quality care, and continued professional and personal development for oncology nurses. CNE Credits: 1.0 ANCC Contact Hour. Accreditation Statement Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hours of continuing nursing education of RNs and APNs. Disclosure Policy Statement In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. Disclosure Of Unlabeled Use Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. Disclaimer Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use. For CME questions, please contact: Med Learning Group at info@medlearninggroup.com . Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/ Release date: June 04, 2022 Expiration date: June 04, 2023 Estimated time to completion: 1 hour Faculty Alok A. Khorana, MD, FACP, FASCO Professor of Medicine Taussig Cancer Institute and Case Comprehensive Cancer Center Cleveland Clinic Cleveland, OH We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it....
Domain Name: CME-LMS.COM Registry Domain ID: 2495200784_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-11-17T01:51:14Z Creation Date: 2020-02-21T15:07:36Z Registry Expiry Date: 2025-02-21T15:07:36Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS39.DOMAINCONTROL.COM Name Server: NS40.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-18T01:37:47Z <<<